OIA
CRVS icon

OneDigital Investment Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

OneDigital Investment Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157K Buy
10,716
+716
+7% +$11.4K ﹤0.01% 1411
2025
Q4 		$77K Hold
10,000
– – ﹤0.01% 1479
2025
Q3 		$73.7K Hold
10,000
– – ﹤0.01% 1462
2025
Q2 		$40K Buy
+10,000
New +$36.4K ﹤0.01% 1433
2024
Q4 		– Sell
-10,000
Closed -$52.8K – 1424
2024
Q3 		$52.8K Sell
10,000
-4,550
-31% -$16.3K ﹤0.01% 1410
2024
Q2 		$26.5K Sell
14,550
-3,400
-19% -$6.33K ﹤0.01% 1349
2024
Q1 		$32K Buy
17,950
+5,550
+45% +$11.6K ﹤0.01% 1072
2023
Q4 		$21.8K Buy
+12,400
New +$18.1K ﹤0.01% 1095

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OneDigital Investment Advisors's CRVS Position: Q1 2026 in Review

OneDigital Investment Advisors increased its Corvus Pharmaceuticals (CRVS) stake by 7.2% in Q1 2026, buying an estimated $11.4K and bringing the position to 10,716 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

OneDigital Investment Advisors first reported a position in CRVS in Q4 2023 and has held it in 8 quarters since. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • OneDigital Investment Advisors held 10,716 shares of Corvus Pharmaceuticals worth $157K as of Q1 2026.
  • OneDigital Investment Advisors bought 716 Corvus Pharmaceuticals shares in Q1 2026, an estimated $11.4K.
  • Corvus Pharmaceuticals made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #1411 holding.
  • OneDigital Investment Advisors first reported a position in Corvus Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.